LYMPHOMA, MANTLE CELL
Clinical trials for LYMPHOMA, MANTLE CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, MANTLE CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, MANTLE CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called LY4152199 in about 215 adults with certain types of blood cancer (like follicular lymphoma or diffuse large B-cell lymphoma) that have already been treated. The drug is designed to help the body's immune cells attack the cancer. The …
Matched conditions: LYMPHOMA, MANTLE CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug MTM-H-001 takes on tough blood cancers
Disease control Not yet recruitingThis early study tests a new drug called MTM-H-001 in 69 adults with B-cell blood cancers (like certain lymphomas and leukemias) that have come back or stopped responding to treatment. The main goal is to check safety and find the right dose, while also seeing if it can shrink tu…
Matched conditions: LYMPHOMA, MANTLE CELL
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC